Pneumatosis Cystoides Intestinalis Following Lupus Enteritis and Peritonitis
スポンサーリンク
概要
- 論文の詳細を見る
We describe a case of systemic lupus erythematosus (SLE) with enteritis and peritonitis who later developed pneumatosis cystoides intestinalis (PCI). A 35-year-old woman with SLE relapsed with enteritis and peritonitis. Prednisolone (PSL) effectively improved her symptoms. However, 6 weeks later, she developed PCI. Tapering of PSL, administration of intravenous cyclophosphamide, prokinetic agents and antibiotics, bowel rest with intravenous hypernutrition therapy and hyperbaric oxygen therapy successfully improved PCI. Although PCI is a rare complication of SLE, the present case suggests that lupus enteritis could be a risk factor for PCI, and that high-dose PSL could cause additional insult to PCI.
著者
-
Miyasaka Nobuyuki
Department Of Bioregulatory Medicine And Rheumatology Faculty Of Medicine Tokyo Medical And Dental U
-
Nanki Toshihiro
Department Of Internal Medicine And Harold C. Simmons Arthritis Research Center University Of Texas
-
Mizoguchi Fumitaka
Department Of Medicine And Rheumatology Graduate School Tokyo Medical And Dental University
-
MIYASAKA Nobuyuki
Department of Medicine and Rheumatology, Graduate School, Tokyo Medical and Dental University
関連論文
- Infected abdominal aortic aneurysm caused by nontyphoid Salmonella in an immunocompromised patient with rheumatoid arthritis
- Reevaluation of antibody titers 1 year after influenza vaccination in patients with rheumatoid arthritis receiving TNF blockers
- Anti-tumor necrosis factor therapy does not diminish the immune response to influenza vaccine in Japanese patients with rheumatoid arthritis
- A case of Muckle-Wells syndrome caused by a novel H312P mutation in NALP3 (cryopyrin)
- A case of paraneoplastic syndrome mimicking adult-onset Still's disease
- Development of TCRB CDR3 length repertoire of human T lymphocytes
- Two cases of acute respiratory distress syndrome resulting from adult-onset Still's disease
- Suppression of arthritis by forced expression of cyclin-dependent kinase inhibitor p2l^ gene into the joints
- Treatment of Arthritis with Cyclin-dependent Kinase Inihibitor Gene
- Efficacy of combination treatment with cyclosporin A and corticosteroids for acute interstitial pneumonitis associated with dermatomyositis
- Pulmonary Exercise Testing Predicts Prognosis in Patients with Chronic Obstructive Pulmonary Disease
- Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis : results from the RISING study
- Cognitive dysfunction in systemic lupus erythematosus
- Inflammatory Cytokines as a Molecular Target in the Treatment of Inflammatory Disorders of Unknown Etiology
- Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis
- Prediction of and prophylaxis against Pneumocystis pneumonia in patients with connective tissue diseases undergoing medium- or high-dose corticosteroid therapy
- Clinical investigation in highly disease-affected rheumatoid arthritis patients in Japan with adalimumab applying standard and general evaluation : the CHANGE study
- Revised Japanese criteria for Sjogren's syndrome (1999) : availability and validity
- Augmented Expression of CD44 Splice Variants in Lymphoproliferative Disorder of the Lacrimal Gland in Sjogren's Syndrome
- Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis
- Leflunomide-related acute interstitial pneumonia in two patients with rheumatoid arthritis : autopsy findings with a mosaic pattern of acute and organizing diffuse alveolar damage
- Varicella-zoster virus hepatitis in polymyositis
- Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis
- Guidelines for the proper use of etanercept in Japan
- Multicenter cooperative study of HLA class II alleles in Japanese patients with systemic lupus erythematosus
- Pneumatosis Cystoides Intestinalis Following Lupus Enteritis and Peritonitis
- Efficacy and safety of tacrolimus for lupus nephritis : a placebo-controlled double-blind multicenter study
- The effect of synthetic retinoid, Am80, on T helper cell development and antibody production in murine collagen-induced arthritis
- Lack of correlation between chemokine receptor and T_h1/ T_h2 cytokine expression by individual memory T cells
- Response of early active rheumatoid arthritis to tumor necrosis factor inhibitors : evaluation by magnetic resonance imaging
- Etanercept-induced necrotizing crescentic glomerulonephritis in two patients with rheumatoid arthritis
- The REAL database reveals no significant risk of serious infection during treatment with a methotrexate dose of more than 8mg/week in patients with rheumatoid arthritis
- A case of IgG4-related disease with features of Mikulicz's disease, and retroperitoneal fibrosis and lymphadenopathy mimicking Castleman's disease
- A case of Behcet's disease with widespread perforating enteric ulcers preceded by a long history of peripheral gangrene
- Effects of intravenous immunoglobulin therapy in Japanese patients with polymyositis and dermatomyositis resistant to corticosteroids : a randomized double-blind placebo-controlled trial
- Addition of the collagen binding domain of fibronectin potentiates the biochemical availability of hepatocyte growth factor for cutaneous wound healing
- Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis : a retrospective review of 15 cases and analysis of risk factors
- Discontinuation of adalimumab treatment in rheumatoid arthritis patients after achieving low disease activity
- Overlap Syndrome with Cerebral Hemorrhage caused by Prostaglandin E1 Infusion.
- A retrospective study of serum KL-6 levels during treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients : a report from the Ad Hoc Committee for Safety of Biological DMARDs of the Japan College of Rheumatology
- Phase II dose-response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate
- Tolerability and effecacy of abatacept in Japanese patients with rheumatoid arthritis : a phase I study